EANS-Adhoc: LifeWatch Announces the World's First iPad ECG Report Viewers

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

New Products/LifeWatch AG

11.05.2010

Chicago, IL / USA May 11 2010 -LifeWatch Services, Inc., a subsidiary
of LifeWatch AG (SIX Swiss Exchange: LIFE), will announce the launch
of their remote ECG report TeleViewer application for the Apple iPad.
The iPad application integrates with and enhances the advanced
reporting and workflow management capabilities present in their web
based applications for all product offerings. The LifeWatch
TeleViewer will also be part of their newly announced series of
remote patient monitoring service packages called TeleClinics. The
iPad's ease-of-use, portability, convenience and multi-touch
capabilities are well suited to the timely review of patient remote
monitoring reports that provide comprehensive and actionable
information for Physicians. These features will help physicians
increase their productivity and standard of care through a
streamlined work flow and immediate access to critical patient data
that enables faster diagnosis and better treatment options, and to
this end, helps eliminate unnecessary and costly hospitalizations and
readmissions.

LifeWatch's TeleViewer can help reduce risk of error as patient care
is increasingly handed off from one doctor to another. It makes
keeping in touch with LifeWatch and the patient a simple and easy
task. The physician benefit is increased productivity, streamlined
work and data flow making more time for patient care.

The TeleViewer takes advantage of the large iPad screen to produce
clear and accurate viewing images of both reports and ECG strips.

The new (Atrial Fibrillation) AF TeleClinic that is being announced
this week at the Heart Rhythm Society meeting in Denver will be
available on the TeleViewer. LifeWatch will provide iPad TeleViewers
to physicians enrolled in the AF TeleClinic service. AF TeleClinic is
a treatment-focused service package that provides a standard panel of
monitoring tests at pre-set intervals and advanced analysis reporting
tools for post- procedure AF patients.

LifeWatch is focusing on ability to deliver the remote patient
monitoring data to physicians and clinicians anytime, anywhere.

"Bringing the iPad's innovative multi-touch apps and the e-book
reader functionality to the medical community makes it perfect for
enabling physicians to review and read reports on their patients
being monitored remotely", stated Brent Cohen, CEO ,LifeWatch AG."
Other versions of the TeleClinic using the TeleViewer will be
launched in the near future, including TeleClinics for Stroke,
Syncope and Obstructive Sleep Apnea management."

About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on
SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare
technology and solution company, specializing in advanced telehealth
systems and wireless remote patient monitoring services. LifeWatch
services cater to individuals, ranging from high-risk and chronically
ill patients, to consumers of health and wellness products. LifeWatch
has subsidiaries in the United States, the Netherlands, Japan, the
United Kingdom, Switzerland and Israel. LifeWatch AG is the parent
company of LifeWatch Services Inc., a leading US-based cardiac
monitoring service provider, and manufacturer of telecardiology
products. LifeWatch is also introducing a new program for Home
SleepTesting of Obstructive Sleep Apnea (OSA) patients under the
brand name NiteWatch. For additional information, please visit
{www.lifewatch.com}[HYPERLINK: http://www.lifewatch.com] and
{www.nitewatchservices.com}[HYPERLINK:
http://www.nitewatchservices.com]

Sign-up for customized E-mail alerts and documentation requests is
available at http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results of
operations and financial position, business strategy and plans and
objectives for future operations, are forward-looking statements. The
words "believe," "may," "will," "estimate," "continue," "anticipate,"
"intend," "expect" and similar expressions are intended to identify
forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business
strategy, short term and long term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking
events and circumstances described may not occur and actual results
could differ materially and adversely from those anticipated or
implied in the forward-looking statements. All forward-looking
statements are based only on data available to LifeWatch AG at the
time of the issue of this press release. LifeWatch AG does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.

Apple is a trademark of Apple Inc., registered in the U.S. and other
countries. iPad is a trademark of Apple Inc.

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: LifeWatch AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Woo Kim, Senior Vice President of Strategy and Business Development, LifeWatch

Tel +1 847 813 4299 | Fax +1 847 813 24 48 | Email
{wkim@lifewatch.com}[HYPERLINK: mailto:wkim@lifewatch.com]

Sensus Investor and Public Relations GmbH, Zürich:

Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
SIX Swiss Exchange / Hauptsegment
Berlin / free trade